Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-03-18 12:59 pm Purchase |
2021-03-12 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Sphera Funds Management Ltd. | 33,788 6.290% |
33,788 (New Position) |
Filing History |
| 2021-02-16 09:04 am Sale |
2020-12-31 | 13G | Orgenesis Inc. ORGS |
Sphera Funds Management Ltd. | 52,522 2.130% |
-59,787 (-53.23%) |
Filing History |
| 2021-02-16 09:00 am Unchanged |
2020-12-31 | 13G | Sio Gene Therapies Inc. SIOX |
Sphera Funds Management Ltd. | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2021-02-16 08:57 am Unchanged |
2020-12-31 | 13G | Larimar Therapeutics, Inc. LRMR |
Sphera Funds Management Ltd. | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2021-02-16 08:55 am Purchase |
2020-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR |
Sphera Funds Management Ltd. | 250,000 1.510% |
250,000 (New Position) |
Filing History |
| 2021-02-16 08:52 am Sale |
2020-12-31 | 13G | NEOS THERAPEUTICS INC NEOS |
Sphera Funds Management Ltd. | 0 0.000% |
-3,530,731 (Position Closed) |
Filing History |
| 2021-02-16 06:09 am Sale |
2020-12-31 | 13G | Allot Ltd. ALLT |
Sphera Funds Management Ltd. | 1,129,054 3.210% |
-679,142 (-37.56%) |
Filing History |